CN101156863A - 一种治疗心脑血管疾病的药物组合物及其医药用途 - Google Patents
一种治疗心脑血管疾病的药物组合物及其医药用途 Download PDFInfo
- Publication number
- CN101156863A CN101156863A CNA2007101328102A CN200710132810A CN101156863A CN 101156863 A CN101156863 A CN 101156863A CN A2007101328102 A CNA2007101328102 A CN A2007101328102A CN 200710132810 A CN200710132810 A CN 200710132810A CN 101156863 A CN101156863 A CN 101156863A
- Authority
- CN
- China
- Prior art keywords
- radix paeoniae
- peoniflorin
- lactone glucoside
- pharmaceutical composition
- glucoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量 | 梗塞脑组织重量百分比 | 抑制率 |
ShamNS灯盏花素芍药苷芍药内酯苷芍药苷∶芍药内酯苷(10∶1)芍药苷∶芍药内酯苷(15∶1)芍药苷∶芍药内酯苷(20∶1)芍药苷∶芍药内酯苷(25∶1) | 10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg | 3.8±5.0**36.2±8.828.4±6.726.3±5.4*27.2±6.225.4±5.1*24.2±4.3**23.7±4.5**25.5±5.9* | 21.5%27.3%24.9%29.8%33.1%34.5%29.6% |
组别 | 剂量 | 行为学评分 |
ShamNS灯盏花素芍药苷芍药内酯苷芍药苷∶芍药内酯苷=10∶1芍药苷∶芍药内酯苷=15∶1芍药苷∶芍药内酯苷=20∶1芍药苷∶芍药内酯苷=50∶1 | 10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg | 0±0**5.2±4.82.8±1.72.3±1.42.2±1.2*1.7±0.9**1.2±0.7**0.7±0.5**1.5±0.9** |
组别 | 剂量 | 血栓 | ||
对照组灯盏花素芍药苷芍药内酯苷芍药苷∶芍药内酯苷=10∶1 | 10mg\kgl0mg\kg10mg\kg10mg\kg | 长度23.1±1.220.8±1.419.7±1.621.2±1.418.3±1.3 | 湿重151.3±12.1128.4±20.7127.3±19.4130.2±21.2127.0±13.1 | 干重26.9±1.622.6±5.921.7±4.223.2±3.821.0±3.1 |
芍药苷∶芍药内酯苷=15∶1芍药苷∶芍药内酯苷=20∶1芍药苷∶芍药内酯苷=50∶1 | 10mg\kg10mg\kg10mg\kg | 17.2±1.815.7±1.016.3±1.2 | 126.2±14.3126.5±12.5127.2±17.9 | 20.3±2.319.5±3.821.5±2.7 |
组别 | 剂量 | 凝血时间 |
生理盐水组芍药苷芍药内酯苷芍药苷∶芍药内酯苷=10∶1芍药苷∶芍药内酯苷=15∶1芍药苷∶芍药内酯苷=20∶1芍药苷∶芍药内酯苷=50∶1 | 10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg10mg\kg | 54.7±10.262.8±11.364.9±11.065.3±12.969.8±12.170.0±11.468.7±10.9 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101328102A CN101156863B (zh) | 2007-09-30 | 2007-09-30 | 一种治疗心脑血管疾病的药物组合物及其医药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101328102A CN101156863B (zh) | 2007-09-30 | 2007-09-30 | 一种治疗心脑血管疾病的药物组合物及其医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101156863A true CN101156863A (zh) | 2008-04-09 |
CN101156863B CN101156863B (zh) | 2010-09-08 |
Family
ID=39305184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101328102A Expired - Fee Related CN101156863B (zh) | 2007-09-30 | 2007-09-30 | 一种治疗心脑血管疾病的药物组合物及其医药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101156863B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102038701B (zh) * | 2009-10-20 | 2012-06-27 | 张作光 | 芍药内酯苷的抗抑郁用途 |
CN104706647A (zh) * | 2012-05-15 | 2015-06-17 | 北京京朋汇药业研究发展有限公司 | 芍药内酯苷在制备抗胰腺癌药物中的用途 |
CN105640974A (zh) * | 2016-01-25 | 2016-06-08 | 河南大学 | 芍药内酯苷在制备抗血栓药物方面的应用 |
US9453041B2 (en) | 2010-11-10 | 2016-09-27 | Zuoguang Zhang | Method for preparing albiflorin and paeoniflorin |
CN107496434A (zh) * | 2017-01-06 | 2017-12-22 | 张作光 | 芍药内酯苷作为吲哚胺2,3‑双加氧酶(ido)抑制剂的用途 |
CN110664809A (zh) * | 2019-10-14 | 2020-01-10 | 佳木斯大学 | 一种防治脑梗塞的药物组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1314403C (zh) * | 2002-10-29 | 2007-05-09 | 沈阳药科大学 | 芍药苷和芍药内酯苷的组合物及其制备方法 |
CN1765366A (zh) * | 2004-10-27 | 2006-05-03 | 李红侠 | 白芍总苷片及其制备方法 |
CN1706397B (zh) * | 2005-02-04 | 2011-11-16 | 沈阳药科大学 | 具有升高白细胞作用的芍药苷与芍药内酯苷的组合物 |
-
2007
- 2007-09-30 CN CN2007101328102A patent/CN101156863B/zh not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102038701B (zh) * | 2009-10-20 | 2012-06-27 | 张作光 | 芍药内酯苷的抗抑郁用途 |
US9453041B2 (en) | 2010-11-10 | 2016-09-27 | Zuoguang Zhang | Method for preparing albiflorin and paeoniflorin |
CN104706647A (zh) * | 2012-05-15 | 2015-06-17 | 北京京朋汇药业研究发展有限公司 | 芍药内酯苷在制备抗胰腺癌药物中的用途 |
CN105640974A (zh) * | 2016-01-25 | 2016-06-08 | 河南大学 | 芍药内酯苷在制备抗血栓药物方面的应用 |
CN107496434A (zh) * | 2017-01-06 | 2017-12-22 | 张作光 | 芍药内酯苷作为吲哚胺2,3‑双加氧酶(ido)抑制剂的用途 |
CN110664809A (zh) * | 2019-10-14 | 2020-01-10 | 佳木斯大学 | 一种防治脑梗塞的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101156863B (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101156863B (zh) | 一种治疗心脑血管疾病的药物组合物及其医药用途 | |
WO2005051404A1 (en) | Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases | |
CN106581335A (zh) | 治疗老年痴呆症的药物组合物及其制备方法和用途 | |
CN100566720C (zh) | 一种治疗心脑血管疾病的中药有效成分组合物及其用途 | |
CN106361811B (zh) | 一种通脉药物组合物及其制备方法 | |
CN109745384A (zh) | 代代花有效部位或有效成分在制备治疗心脑血管系统缺血性疾病药物中的应用及其制备方法 | |
CN1857385B (zh) | 一种治疗颈椎病的药物组合物及其制备方法 | |
KR20070017944A (ko) | 단삼, 그 추출물 및 조성물을 이용한 아스피린 내성 치료제 | |
CN102764280A (zh) | 含有牛黄,麝香的药物组合及其应用 | |
CN102614234B (zh) | 抗中风药物组合物及片剂及其制备方法 | |
CN102018740B (zh) | 含有向日葵叶提取物的药物组合物及其用途 | |
CN104288169B (zh) | 一种黄酮苷类化合物及其制备方法和用途 | |
CN103356731A (zh) | 含有杜仲提取物与三七总皂苷的血塞通片及其应用 | |
CN111759891B (zh) | 一种用于治疗心肌缺血的药物组合物及其应用 | |
CN107693576A (zh) | 一种用于治疗冠心病的中药组合物 | |
CN103830353A (zh) | 一种药物组合物及应用 | |
CN103893368B (zh) | 无糖型仙灵地黄组合物及其颗粒剂和制法 | |
CN1868507B (zh) | 一种药物组合物及其制备方法和应用 | |
CN101642479B (zh) | 三七有效部位r,其药物组合物,其制备方法和其用途 | |
CN1969892A (zh) | 治疗心脑血管疾病的药物组合物及其制备方法和质控方法 | |
CN110882392A (zh) | 一种用于缓解和/或治疗炎性疾病的药物组合物 | |
CN1969917A (zh) | 治疗心脑血管疾病的药物组合物及其制备方法和质控方法 | |
CN1969977A (zh) | 治疗心脑血管疾病的药物组合物及其制备方法和质控方法 | |
CN100998600A (zh) | 治疗心脑血管疾病的中药制剂及其制备方法和应用 | |
CN107213193A (zh) | 野生苦豆子在止血和促进伤口愈合方面的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080229 Address after: Five hundred and ten thousand six hundred and sixty No. 80 Guangzhou science and technology innovation base in D District 401403 city moon road in Guangzhou city of Guangdong province science, Postal Code: 510660 Applicant after: Guangzhou Aige Biotech Co., Ltd. Address before: Dirt road, Jiangning District, Nanjing, Jiangsu Applicant before: Nanjing Kewen Biological Technology Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU YINGKE BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GUANGZHOU AIGE BIOTECH CO., LTD. Effective date: 20130106 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510660 GUANGZHOU, GUANGDONG PROVINCE TO: 225300 TAIZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130106 Address after: 225300 G41 workshop, Chinese medicine city, Taizhou, Jiangsu Patentee after: JIANGSU YINGKE BIOLOGICAL PHARMACEUTICAL CO., LTD. Address before: The city on 510660 Guangzhou Road, Guangdong province science and technology innovation base of Guangzhou No. 80 D District 401-403 Patentee before: Guangzhou Aige Biotech Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100908 Termination date: 20160930 |
|
CF01 | Termination of patent right due to non-payment of annual fee |